Cargando…
Microglia P2X4 receptors as pharmacological targets for demyelinating diseases
Pharmacological activation of the P2X4 receptor expressed by brain microglia may provide a novel avenue to promote remyelination and improve clinical symptoms in experimental autoimmune encephalomyelitis and potentially in multiple sclerosis.
Autores principales: | Di Virgilio, Francesco, Sarti, Alba Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079532/ https://www.ncbi.nlm.nih.gov/pubmed/30037978 http://dx.doi.org/10.15252/emmm.201809369 |
Ejemplares similares
-
A rationale for targeting the P2X7 receptor in Coronavirus disease 19
por: Di Virgilio, Francesco, et al.
Publicado: (2020) -
The fifth element: a novel eIF2α kinase in microglia
por: Ruggieri, Alessia
Publicado: (2023) -
Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine
por: Chiozzi, Paola, et al.
Publicado: (2019) -
P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
por: Sarti, Alba Clara, et al.
Publicado: (2021) -
The P2X7 Receptor-Interleukin-1 Liaison
por: Giuliani, Anna Lisa, et al.
Publicado: (2017)